mirtazapine has been researched along with Multiple Myeloma in 2 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Multiple Myeloma: A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "An 83-year-old man presented with visual disturbance and right hemiparalysis, one month after daratumumab, bortezomib, and dexamethasone administration for multiple myeloma (MM)." | 8.31 | [A case of progressive multifocal leukoencephalopathy associated with daratumumab, bortezomib, and dexamethasone for multiple myeloma]. ( Enomoto, S; Hamano, T; Kitazaki, Y; Morita, M; Nakamichi, K; Usui, K, 2023) |
| "An 83-year-old man presented with visual disturbance and right hemiparalysis, one month after daratumumab, bortezomib, and dexamethasone administration for multiple myeloma (MM)." | 4.31 | [A case of progressive multifocal leukoencephalopathy associated with daratumumab, bortezomib, and dexamethasone for multiple myeloma]. ( Enomoto, S; Hamano, T; Kitazaki, Y; Morita, M; Nakamichi, K; Usui, K, 2023) |
| "A patient with multiple myeloma was treated with high-dose chemotherapy followed by two autologous bone marrow transplantations (ABMTs)." | 1.37 | Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option. ( Brustia, D; Cantello, R; Comi, C; Conconi, A; De Paoli, L; Gaidano, G; Monaco, F; Mula, M; Nasuelli, N; Ripellino, P; Savio, K; Stecco, A; Varrasi, C, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Usui, K | 1 |
| Kitazaki, Y | 1 |
| Enomoto, S | 1 |
| Morita, M | 1 |
| Nakamichi, K | 1 |
| Hamano, T | 1 |
| Ripellino, P | 1 |
| Comi, C | 1 |
| Mula, M | 1 |
| Varrasi, C | 1 |
| Conconi, A | 1 |
| Stecco, A | 1 |
| Brustia, D | 1 |
| Nasuelli, N | 1 |
| Savio, K | 1 |
| De Paoli, L | 1 |
| Cantello, R | 1 |
| Gaidano, G | 1 |
| Monaco, F | 1 |
2 other studies available for mirtazapine and Multiple Myeloma
| Article | Year |
|---|---|
[A case of progressive multifocal leukoencephalopathy associated with daratumumab, bortezomib, and dexamethasone for multiple myeloma].
Topics: Aged, 80 and over; Bortezomib; Dexamethasone; DNA, Viral; Humans; JC Virus; Leukoencephalopathy, Pro | 2023 |
Progressive multifocal leucoencephalopathy after autologous bone marrow transplantation: a treatment option.
Topics: Antidepressive Agents, Tricyclic; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Cytosine | 2011 |